BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
    • Interviews
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » video

Top 3 Stem Cell Videos on YouTube

October 23, 2018 By Cade Hildreth (CEO) 1 Comment

youtube stem cell therapy | Top 3 Stem Cell Videos on YouTube

If you’re looking for an informative stem cells video on YouTube, check out this top 3 list.

In this article:

  1. An Introduction
  2. The Skin Gun
  3. Transplant Cells, Not Organs TED Talk
  4. Stem Cells and the Future of Medicine – Research on Aging

[Read more…]

Filed Under: Stem Cells Tagged With: Skin Gun, video, YouTube

Top Stem Cell Video of the Year! (3 Minutes)

June 6, 2016 By Cade Hildreth (CEO) 5 Comments

Stem Cell Video

This video published by the Harvard School of Medicine is incredible, winning our award for the “Best Stem Cell Video of the Year.”

It is a zebrafish animation that shows the discoveries made by the Stem Cell Research Program at Boston Children’s Hospital.

Using the zebrafish as a model, it takes you from the birth of a blood stem cell, along its travel through the body, to its site of engraftment.
[Read more…]

Filed Under: HSCs, Stem Cells Tagged With: harvard school of medicine, hematopoietic stem cells, living system, stem cells, video

Cynata CEO Describes Technical and Strategic Advances of Company’s Cymerus™ Technology

December 9, 2015 By Cade Hildreth (CEO) Leave a Comment

Cynata, Dr. Macdonald Speaks at Stem Cell Meeting on the Mesa

In this video released by the Alliance for Regenerative Medicine (ARM), Dr. Ross Macdonald, Managing Director and CEO of Cynata Therapeutics, speaks about the technical and strategic advantages of the company’s Cymerus™ technology platform, as well as the company’s growth potential.

 

Key highlight from the talk include:  

  • Cynata Therapeutics is an Australian stock exchange listed company (ASX: CYP)
  • Commenced operations in November 2013
  • Market cap of USD $23M
  • 2 years of cash available for ongoing operations
  • Recently raised AUD $5M in a placement in the U.S. that involved three institutional investors
  • 72.7M shares on issue; 1,900 shareholders
  • Company is focused on the development of a novel process for the manufacture of mesenchymal stem cells (MSCs)
  • Investigating how to utilize the company’s key technology (Cymerus™ platform) to address major unmet medical needs
  • MSCs have a characteristic of honing to solid tumor sites, so genetic engineering of MSCs may allow them to be used as a type of “Trojan Horse” to selectively kill cancer cells
  • Cymerus™ technology can provide lower cost manufacture of high-quality, consistent, reproducible MSCs, overcoming the traditionally high costs associated with stem cell therapies
  • The Cymerus™ technology utilizes a single donation from a single donor to provide infinite expansion capacities for MSCs
  • Cymerus™ technology eliminates the need for multiple donors and donor-to-donor variability
  • The Cymerus™ technology is a “transformative technology” for commercializing MSC therapeutics
  • Cynata is exploring potential corporate partnerships to drive further development and commercialization of the Cymerus™ technology
  • The company has achieved several major milestones, including process validation of its manufacturing methodology
  • The company is developing a schedule for its Phase I clinical study to be conducted in GvHD patients
  • The company will be reporting preclinical data from its pre-clinical program, in  particular, a proof-of-concept study in a GvHD model

To learn more about Cynata Therapeutics, view recent research coverage of the company released by Rodman & Renshaw.


Want to be better informed than your competition? Get future stem cell industry updates.

 

About Us

BioInformant is the only research firm that has served the stem cell sector since it emerged. BioInformant research has been cited by major news outlets that include the Wall Street Journal, Nature Biotechnology, CBS News, Medical Ethics, and the Center for BioNetworking. Serving Fortune 500 leaders that include GE Healthcare, Pfizer, and Goldman Sachs, BioInformant is your global leader in stem cell industry data.

Click here to view our global strategic reports for the stem cell and cord blood industry.

Filed Under: iPS Cells, MSCs, Stem Cells Tagged With: Cymerus, cynata therapeutics, market news, mesenchymal stem cells, stem cells, video

Nanocellect

Marathon Products

Kimera Society

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram

Cart

Top Rated Products

  • Job Posting on BioInformant <Job Posting on BioInformant.com - Your Perfect Hire Is In Our Audience $297
  • U.S. Cord Blood Banking Survey <Cord Blood Banking Survey of U.S. Parents [2017] $197
  • Exosome Companies 2020 <Global Database of Exosome Companies $149 $97
My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: [email protected] | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.